The Impact of U3 Devices on Forensic Analysis

Flash and USB portable drives are now in common place use in computing environments. The U3 smart drive is one emerging type of enhanced flash drive. It is believed that U3 smart drive devices do not leave any record or evidence on a host PC after use. Therefore, it is conceivable that it could be used in a digital crime or attack on a computer or networked system. In circumstances where a portable device such as a U3 has been used, it is more complex for a forensic analyst to find evidence of its use. This paper discusses the impact of U3 smart drive devices on a forensic investigation. Further, it describes the forensic investigation undertaken of a computer in which U3 was used

A Study on Information Induced Medication Errors

Preventable medical adverse events are a serious concern for healthcare. Medication errors form a significant part of these concerns and it is evident that these errors can have serious consequences such as death or disability. Many medication errors are a consequence of information failure. Therefore to prevent such adverse events, the associated information flow must be understood. This research used a systematic review methodology to conduct an analysis of medication error as a result of information failure. Its aim was to suggest solutions on reducing information induced medication errors. The results indicate that is apparent that human error such as slips or lapses can occur due to stress, tiredness and interruptions within the clinical process. Numerous information flow problems are evident within the clinical culture and it is this clinical culture that allows human error which results in medication errors. By changing the clinical culture and establishing effective information flow, clinical errors may be reduced. Thus, recommendations for reducing information flow induced medication errors include a change in clinical culture and the design of a framework which can establish uniformity of communication between healthcare providers. Finally, a major concern for patients is lack of patient information such as medication histories and allergies. Reconciliation of medication histories and a data base of patient information can assist practitioners in identifying any allergies to medications and thus prevent patient allergy related medication errors. Patient health summaries should be shared, for instance using the Australian national eHealth record in order to reduce errors in transcription and to reduce the time spent on collecting medication history

Virtual Environments Support Insider Security Violations

This paper describes an investigation into how an employee using a virtual environment can circumvent any or all of the security, policies and procedures within an organization. The paper discusses the fundamental issues that organizations must address to be able to detect such an attack. Attacks of this nature may be malicious with intent to cause disruption by flooding the network or disabling specific equipment, or non-malicious by quietly gathering critical information such as user names and passwords or a colleague’s internet banking details. Identification of potential residual evidence following an attack is presented. Such evidence may be used to speculate or verify an attack incident occurrence. Additionally, the forensic extraction of any such evidence is discussed. Finally, the paper raises the possibility of a virtual machine being used as an anti-forensic tool to destroy incriminating evidence in such circumstances

Developing a Mobile Audiometric Sound Booth Application for Apple IOS Devices

Hearing loss in Australian children, particularly those in rural and remote areas, is a growing health concern. Resultant deafness has significant impact on the educational and social development of such children. Whilst telehealth had provided other benefits for rural and remote areas, the absence of suitable testing equipment and associated healthcare specialists has meant that there is a gap in this area of child health that could be addressed using a mobile solution. This paper discusses the research and development of a mobile application for testing and diagnosis of hearing loss in children. It is unique in its ability to be able to function in uncontrolled test environments, and conforms to current hearing assessment standards. The application also produces an audiogram that can be immediately electronically transferred to the relevant healthcare provider. The application is specifically designed for young children to use and is designed to be used in collaboration with healthcare specialist audiologists and paediatricians. The prototype is currently undergoing testing at the Telethon Speech and Hearing institute, Perth, Western Australia. The results are expected to deliver crucial quantitative data to determine the accuracy of the application, as well as qualitative data from healthcare professionals and consumers

Cybersecurity Vulnerabilities in Medical Devices: A Complex Environment and Multifaceted Problem

The increased connectivity to existing computer networks has exposed medical devices to cybersecurity vulnerabilities from which they were previously shielded. For the prevention of cybersecurity incidents, it is important to recognize the complexity of the operational environment as well as to catalog the technical vulnerabilities. Cybersecurity protection is not just a technical issue; it is a richer and more intricate problem to solve. A review of the factors that contribute to such a potentially insecure environment, together with the identification of the vulnerabilities, is important for understanding why these vulnerabilities persist and what the solution space should look like. This multifaceted problem must be viewed from a systemic perspective if adequate protection is to be put in place and patient safety concerns addressed. This requires technical controls, governance, resilience measures, consolidated reporting, context expertise, regulation, and standards. It is evident that a coordinated, proactive approach to address this complex challenge is essential. In the interim, patient safety is under threat

The Impact of Waste Heat Release on Simulated Global Climate

The general circulation model of the United Kingdom Meteorological Office (UKMO) has been used to investigate the effects of thermal pollution from large-scale energy parks on climate. Two scenarios, with different locations for the energy parks, have been considered. Emphasis was placed on finding an estimate of model variability (on the basis of three control cases), so that the significance of the change caused by the heat release could be evaluated. As far as the model climatology is concerned, significant changes were produced by the energy parks. In addition, the location of the parks influenced the model response. The presently available models do not simulate climate in a completely realistic way so that the results of sensitivity experiments must be interpreted very carefully. At the present stage it can be said that the results call for further investigations

Immediate Hemodynamic Effect of the Additional Use of the SCD EXPRESS™ Compression System in Patients with Venous Ulcers Treated with the Four-layer Compression Bandaging System

ObjectivesTo test the hypothesis that the SCD EXPRESS™ intermittent pneumatic compression applied in combination with a four-layer bandage in patients with venous ulcers increases popliteal vein volume flow and velocity.DesignTwenty limbs of 18 patients with venous leg ulcers were studied, median age 76 years. The Total Volume Flow (TVF) and the Peak Systolic Velocity (PSV) were recorded in the popliteal vein using duplex ultrasonography. Measurements were made (i) without bandage, (ii) with four layer bandage and (iii) following the application of the SCD Compression System on top of a four-layer bandage for at least 15 minutes.ResultsThe median VCSS was 17 (range, 12–22) while the median VSDS for reflux was 4.5 (range, 1–7.5). The median TVF was 71mL/min (inter-quartile range 57–101) without bandage, 112 (IQR 89–148) with four-layer bandage and 291 (IQR 241–392) with the addition of the SCD System (P<.001, Wilcoxon signed ranks test). The median PSV was 8.4cm/sec (IQR 6.8–14) without bandage, 13 (9.0–19) with four-layer bandage and 27 (21–31) with the addition of the SCD System (P<.001, Wilcoxon signed ranks test). Both TVF and PSV increased slightly with the addition of the four-layer bandage. However, with the addition of the SCD System these parameters increased three fold.ConclusionsThe SCD EXPRESS Compression System accelerates venous flow in the legs of patients with venous ulcers already treated with a four-layer bandage. The combination of four-layer compression with the SCD System on healing venous ulcers needs to be tested by a clinical effectiveness study

Added dietary cobalt or vitamin B12, or injecting vitamin B12 does not improve performance or indicators of ketosis in pre- and post-partum Holstein-Friesian dairy cows

Vitamin B12 is synthesised in the rumen from cobalt and has a major role in metabolism in the peripaturient period, although few studies have evaluated the effect of the dietary inclusion of cobalt (Co), vitamin B12 or injecting vitamin B12 on the metabolism, health and performance of high yielding dairy cows. Fifty-six Holstein-Friesian dairy cows received one of four treatments from 8 weeks prior to calving to 8 weeks post calving: C, no added Co; DC, additional 0.2 mg Co/kg DM; DB, additional 0.68 mg vitamin B12/kg DM; IB, intra-muscular injection of vitamin B12 to supply 0.71 mg/cow/day pre-partum and 1.42 mg/cow/day post-partum. The basal and lactation rations both contained 0.21 mg Co/kg DM. Cows were weighed and condition scored at drying off, 4 weeks prior to calving, within 24 h of calving and at 2, 4 and 8 weeks post-calving, with blood samples collected at drying off, 2 weeks pre-calving, calving and 2, 4 and 8 weeks post-calving. Liver biopsy samples were collected from all animals at drying off and 4 weeks post-calving. Live weight changed with time, but there was no effect of treatment (P>0.05), whereas cows receiving IB had the lowest mean body condition score and DB the highest (P0.05) with mean values of 21.6 kg/day, 39.6 kg/day and 40.4 g/kg respectively. Cows receiving IB had a higher plasma vitamin B12 concentration than those receiving any of the other treatments (P0.05) of treatment on homocysteine or succinate concentrations, although mean plasma methylmalonic acid concentrations were lower (P=0.019) for cows receiving IB than for Control cows. Plasma β-hydroxybutyrate concentrations increased sharply at calving followed by a decline, but there was no effect of treatment. Similarly, there was no effect (P>0.05) of treatment on plasma non-esterified fatty acids or glucose. Whole tract digestibility of DM and fibre measured at week 7 of lactation were similar between treatments, and there was little effect of treatment on the milk fatty acid profile except for C15:0, which was lower in cows receiving DC than IB (P<0.05). It is concluded that a basal dietary concentration of 0.21 mg Co/kg DM is sufficient to meet the requirements of high yielding dairy cows during the transition period, and there is little benefit from additional Co or vitamin B12

Reference genome assembly for Australian Ascochyta rabiei Isolate ArME14

Ascochyta rabiei is the causal organism of ascochyta blight of chickpea and is present in chickpea crops worldwide. Here we report the release of a high-quality PacBio genome assembly for the Australian A. rabiei isolate ArME14. We compare the ArME14 genome assembly with an Illumina assembly for Indian A. rabiei isolate, ArD2. The ArME14 assembly has gapless sequences for nine chromosomes with telomere sequences at both ends and 13 large contig sequences that extend to one telomere. The total length of the ArME14 assembly was 40,927,385 bp, which was 6.26 Mb longer than the ArD2 assembly. Division of the genome by OcculterCut into GC-balanced and AT-dominant segments reveals 21% of the genome contains gene-sparse, AT-rich isochores. Transposable elements and repetitive DNA sequences in the ArME14 assembly made up 15% of the genome. A total of 11,257 protein-coding genes were predicted compared with 10,596 for ArD2. Many of the predicted genes missing from the ArD2 assembly were in genomic regions adjacent to AT-rich sequence. We compared the complement of predicted transcription factors and secreted proteins for the two A. rabiei genome assemblies and found that the isolates contain almost the same set of proteins. The small number of differences could represent real differences in the gene complement between isolates or possibly result from the different sequencing methods used. Prediction pipelines were applied for carbohydrate-active enzymes, secondary metabolite clusters and putative protein effectors. We predict that ArME14 contains between 450 and 650 CAZymes, 39 putative protein effectors and 26 secondary metabolite clusters